Action 300482 GUANGZHOU WONDFO BIOTECH CO.,LTD
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Guangzhou Wondfo Biotech Co.,Ltd

Actions

300482

CNE100002102

Cours en clôture Shenzhen S.E.
Autres places de cotation
 00:00:00 24/04/2024 		Varia. 5j. Varia. 1 janv.
26,9 CNY +4,55 % Graphique intraday de Guangzhou Wondfo Biotech Co.,Ltd +19,08 % -10,84 %
21/04 Guangzhou Wondfo Biotech Co, Ltd publie ses résultats pour le premier trimestre clos le 31 mars 2024 CI
2023 Guangzhou Wondfo Biotech Co.,Ltd publie ses résultats pour les neuf mois se terminant le 30 septembre 2023 CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Guangzhou Wondfo Biotech Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024
Guangzhou Wondfo Biotech Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023
Guangzhou Wondfo Biotech Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2023
Tranche Update on Guangzhou Wondfo Biotech Co.,Ltd's Equity Buyback Plan announced on July 5, 2023.
Guangzhou Wondfo Biotech Co.,Ltd's Equity Buyback announced on July 5, 2023 has closed with 1,121,900 shares, representing 0.25% for CNY 30.1 million.
Guangzhou Wondfo Biotech Co.,Ltd announces an Equity Buyback for CNY 50 million worth of its shares.
Guangzhou Wondfo Biotech Co.,Ltd authorizes a Buyback Plan.
Beijing PolySeq Technology Co., Ltd. announced that it has received CNY 100 million in funding from Guangzhou Wondfo Biotech Co.,Ltd, Guangzhou Sanmei Investment Management Center (Limited Partnership), Shangshi Capital, IDG Capital Partners Co., Ltd., Tsinghua Innovation Ventures
Guangzhou Wondfo Biotech Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023
Guangzhou Wondfo Biotech Co.,Ltd Approves the Cash Dividend for the Year 2022, Payable on 18 May 2023
Announcement on Resolutions of the 2022 Annual General Meeting of Guangzhou Wondfo Biotech
Guangzhou Huiyin Tianyue Nominates Mr.Ge Xinhua as Supervisor
Guangzhou Wondfo Biotech Co.,Ltd Proposes Final Cash Dividend for the Year 2022
Guangzhou Wondfo Biotech Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2022
Beijing PolySeq Technology Co., Ltd. announced that it expects to receive CNY 40 million in funding from Guangzhou Wondfo Biotech Co.,Ltd, Guangzhou Sanmei Investment Management Center (Limited Partnership), Shangshi Capital, IDG Capital Partners Co., Ltd., Tsinghua Innovation Ventures
Investors bet on greed and fear as China loosens COVID grip
Guangzhou Wondfo Biotech Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022
Tranche Update on Guangzhou Wondfo Biotech Co.,Ltd's Equity Buyback Plan announced on September 26, 2022.
Guangzhou Wondfo Biotech Co.,Ltd's Equity Buyback announced on September 26, 2022, has expired with 1,046,200 shares, representing 0.24% for CNY 30.10 million.
Guangzhou Wondfo Biotech Co.,Ltd announces an Equity Buyback for CNY 50 million worth of its shares.
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action 300482
  4. Actualités Guangzhou Wondfo Biotech Co.,Ltd
  5. Autres langues